Search Results - "Murray, K.F"

High Rates of Svr12 in Adolescents Treated with the Combination of Ledipasvir/Sofosbuvir by Schwarz, K, Murray, K.F, Rosenthal, P, Bansal, S, Lin, C.-H, Ni, L, Kanwar, B, Fraser, J, German, P, Brainard, D.M, Wen, J, Gonzalez-Peralta, R, Jonas, M.M, Balistreri, W

Get full text

Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infection by Murray, K.F, Balistreri, W, Bansal, S, Whitworth, S, Evans, H, Gonzalez-Peralta, R.P, Wen, J, Massetto, B, Kersey, K, Zhu, Y, Garrison, K, Svarovskaia, E, Brainard, D.M, Arnon, R, Gillis, L, Jonas, M.M, Lin, C.-H, Narkewicz, M.R, Schwarz, K, Rosenthal, P

Get full text

533 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF TENOFOVIR DF IN ADOLESCENTS WITH CHRONIC HEPATITIS B by Murray, K.F, Szenborn, L, Wysocki, J, Rossi, S, Corsa, A.C, Dinh, P, McHutchison, J.G, Pang, P.S, Luminos, L.M, Pawlowska, M, Mizerski, J

Get full text

800 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON ALFA-2B PLUS RIBAVIRIN PREDICTS LONG-TERM CLEARANCE OF HCV IN PEDIATRIC PATIENTS AT 5 YEAR FOLLOW-UP by Kelly, D, Haber, B, Gonzalez-Peralta, R.P, Murray, K.F, Jonas, M.M, Molleston, J.P, Narkewicz, M.R, Sinatra, F.R, Lang, T, Lachaux, A, Wirth, S, Shelton, M, Te, H.S, Pollack, H, Deng, W, Noviello, S

Get full text

GS17 - High Rates of Svr12 in Adolescents Treated with the Combination of Ledipasvir/Sofosbuvir by Schwarz, K., Murray, K.F., Rosenthal, P., Bansal, S., Lin, C.-H., Ni, L., Kanwar, B., Fraser, J., German, P., Brainard, D.M., Wen, J., Gonzalez-Peralta, R., Jonas, M.M., Balistreri, W.

Get full text

PS-101 - Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infection by Murray, K.F., Balistreri, W., Bansal, S., Whitworth, S., Evans, H., Gonzalez-Peralta, R.P., Wen, J., Massetto, B., Kersey, K., Zhu, Y., Garrison, K., Svarovskaia, E., Brainard, D.M., Arnon, R., Gillis, L., Jonas, M.M., Lin, C.-H., Narkewicz, M.R., Schwarz, K., Rosenthal, P.

Get full text

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial by Richardson, Paul, Soiffer, R.J., Antin, J.H., Jin, Z., Kurtzberg, J., Martin, P.L., Steinbach, G., Murray, K.F., Vogelsang, G.B., Chen, A., Krishnan, A., Kernan, N.A., Avigan, D., Spitzer, T.R., Warren, D., Revta, C., Wei, L.J., Iacobelli, M., McDonald, G.B., Guinan, E.C.

“…Introduction: Severe VOD is an important regimen-related toxicity of hematopoietic SCT characterized by MOF and high mortality (>80% at d+100 post SCT). DF is…”
Get full text

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF by Richardson, Paul G., Soiffer, R.J., Antin, J.H., Jin, Z., Kurtzberg, J., Martin, P.L., Hockenbery, D., Murray, K.F., Vogelsang, G.B., Chen, A., Krishnan, A., Kernan, N.A., Avigan, D., Spitzer, T.R., Warren, D., Momtaz, P., Revta, C., Wei, L.J., Iacobelli, M., McDonald, G.B., Guinan, E.C.

“…Introduction: Veno-Occlusive Disease (VOD) is a significant regimen-related toxicity of hematopoietic stem cell transplant (SCT), which when complicated by…”
Get full text

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings by Richardson, Paul G., Soiffer, R.J., Antin, J.H., Voss, S.D., Jin, Z., Kurtzberg, J., Martin, P.L., Hockenbery, D., Murray, K.F., Vogelsang, G.B., Chen, A., Krishnan, A., Kernan, N.A., Avigan, D., Spitzer, T.R., Iannone, R., Giralt, S., Warren, D., Momtaz, P., Bradwin, G., Iacobelli, M., McDonald, G.B., Guinan, E.C.

“…Introduction: DF, a polydisperse oligonucleotide, has anti-thrombotic, anti-ischemic and thrombolytic properties, especially on microvasculature. Studies have…”
Get full text

Dietary protein intolerance in infants with transient methemoglobinemia and diarrhea by Murray, K F, Christie, D L

“…Of 17 infants requiring hospitalization for primary soy or cow milk protein intolerance, six infants (35%) had transient methemoglobinemia. Reexposure to the…”
Get more information

Congenital microgastria: treatment with transient jejunal feedings by Murray, K.F, Lillehei, C.W, Duggan, C

Get full text